On a recent work trip, I had plenty of things to worry about — but being able to recharge my two smartphones, laptop and iPad were not among my concerns. In my carry-on luggage, I had two medium-cap [...]
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]
In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss dr [...]
It's been almost one year since Intuit shut down the popular budgeting app Mint. I was a Mint user for many years; millions of other users like me enjoyed how easily Mint allowed us to track all [...]
Imagine if you could bring 250 people together in a massive room and have them discuss and debate an important issue, arguing the points and counterpoints, and converging on answers that accurately re [...]
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]